- VDI/VDE Innovation und Technik GmbH
Digital printing of tissue (3D bioprinting) represents a technology with high application potential to generate structured tissues in vitro for applications in the life sciences as well as for regenerative medicine. At the NMI, 3D-bioprinting will be developed to generate micro-tissues in perfusable microfluidic devices to be employed in drug testing applications.
In addition, the use of a special 3D printer for artificial tissue, software developed for this purpose and various biomaterials and processes will be tested in the project. The project is coordinated by the microTEC Südwest e.V. cluster. Innovation perspective The production methods for the creation of artificial tissue are very complex, since a variety of living cells in combination with different biomaterials must be created by a variety of processing and printing methods. With a generic platform for 3D bio-printing, the research project aims to significantly accelerate the pace of innovation in the field of artificial tissue, create new approaches to solutions and make a significant contribution to strengthening the innovation base in Germany. Background In order to develop new market potentials, SMEs are particularly challenged to renew their processes, products and services as well as their business models. SMEs achieve such innovative strength above all within a network, for example in networks and clusters. Under the KMU-NetC funding measure, sophisticated research, development and innovation networks are funded within the framework of networks and clusters with significant participation by small and medium-sized enterprises (SMEs). Cooperation is geared to the needs of SMEs and the innovation strategies or technology roadmaps of networks and clusters. KMU-NetC is part of the "Right of way for SMEs" concept The BMBF's ten-point programme for more innovation in SMEs. With this concept embedded in the Federal Government's new High-Tech Strategy Innovations for Germany, the BMBF is promoting new ideas, new applications and new business models and advocating the widespread dissemination and use of research results and model solutions among SMEs.
- Albert-Ludwigs-Universität Freiburg